SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharmaceuticals raises Rs 350 crore through NCDs

14 Dec 2018 Evaluate

Alembic Pharmaceuticals has raised funds aggregating to Rs 350 crore via private placement. The NCD Committee of the company at their meeting held on December 14, 2018 has allotted 1,500 9% Rated Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of Rs 10 lakh per NCD aggregating to Rs 150 crore under Tranche I, and 2,000 9% Rated Unsecured Listed Redeemable NCDs of Rs 10 lakh per NCD aggregating to Rs 200 crore under Tranche II. The said NCDs shall be listed on the National Stock Exchange of India.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

777.35 -8.30 (-1.06%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.40
Dr. Reddys Lab 1306.80
Cipla 1362.85
Zydus Lifesciences 940.10
Lupin 2459.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×